Glorikian Publications
Listent to Episode Here: http://fticorporate.com/podcasts/harry-glorikian/ Diving with Data – Episode 11:…
What we pay for in healthcare is the real question…
Heathcare’s Digital Future: Telemedicine & Remote Monitoring Every week, news…
MONEYBALL MEDICINE PRICE QUALITY TRANSPARENCY Say you want to open…
Leadership Series: Interview with Harry Glorikian, Partner at New Ventures…
Welcome to the age of MoneyBall Medicine For several years,…
Transforming the Bioresearch and Healthcare Industries Technology and Data Usher…
Why do many IVD companies face an uphill battle with…
Intellectual property considerations for molecular diagnostic development with emphasis on…
MoneyBall Medicine: Thriving in the New Data-Driven Healthcare Market How…
The MoneyBall solution to the healthcare crisis Many recent articles…
What’s the key to efficient IVD development? In the quest…
IVDs and data requirements in a value-based reimbursement landscape The…
This is why pre-design research is essential for the IVD…
How can the in vitro diagnostics industry tap the growth…
Learning from failure: What Theranos, Interleukin Genetics, & Courtagen can…
Do You Have the Data to Benefit from a Post-Keytruda…
MDBR Interviews Harry Glorikian About the Growing Significance of In…
Q&A: Healthcare Industry Expert Harry Glorikian Discusses His New IVD…